Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
Price Target
Average
490.28%
Revenue Forecast
Estimate
11.87%
EBIT
Estimate
5.93%
Net Income
Estimate
28.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sangamo Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SGMO of $5.67 , with forecasts ranging from
a
low of
$2 to a high of $19 .
SGMO Lowest Price Target
Wall Street Target
2 USD
108.33%
SGMO Average Price Target
Wall Street Target
5.67 USD
490.28%
SGMO Highest Price Target
Wall Street Target
19 USD
1879.17%
REVENUE FORECAST
Revenue Forecast Chart SGMO
EBIT FORECAST
EBIT Forecast Chart SGMO
NET INCOME FORECAST
Net Income Chart SGMO